NeoGASTRIC is a multicentre randomised control trial in the UK and Australia looking at whether the routine measurement of gastric residual volumes is good or bad for preterm babies.
NeoGASTRIC Trial
Loading...
The @toast-study.bsky.social Trial Manager is at REaSoN Neonatal Conference today - come and say 'Hello!' 👋at the
@npeu-ctu.bsky.social stand to hear about our current and upcoming trials.
@npeu-oxford.bsky.social
@TOAST_Study looks at whether antacid medication is useful for babies born with a rare condition, oesophageal atresia. It is one of only a few clinical trials in neonatal surgery. Prof. Nigel Hall shares the motivation for the study.
www.npeu.ox.ac.uk/toast
Today is #NECAwarenessDay and we at the NPEU CTU are raising awareness of NEC and the devastating impact it can have on babies and their families. Our research is dedicated to improving evidence-based care and outcomes for newborn babies. 💜
@npeu-oxford.bsky.social @oxfordwomenshealth.bsky.social
This weekend on #NECawarenessday we thank all the 7,427 babies enrolled in the neoGASTRIC trial. These babies and their families are helping neonatal teams better understand whether routine gastric residual volume measurement is beneficial and how we can improve care and prevent NEC
Happy International Nurses day! To all the wonderful Nurses involved in the neoGASTRIC trial thank you and have a wonderful day. #IND #neoGASTRIC @npeu-ctu.bsky.social @npeu-oxford.bsky.social
